<?xml version="1.0" encoding="UTF-8"?>
<p id="Par23">Fifteen hiPSC-PD studies investigating 
 <italic>LRRK2</italic>, 
 <italic>PRKN, SNCA</italic>, and sporadic patient-derived lines reported alterations in neurite process morphology
 <sup>
  <xref ref-type="bibr" rid="CR26">26</xref>,
  <xref ref-type="bibr" rid="CR42">42</xref>,
  <xref ref-type="bibr" rid="CR45">45</xref>,
  <xref ref-type="bibr" rid="CR49">49</xref>,
  <xref ref-type="bibr" rid="CR51">51</xref>,
  <xref ref-type="bibr" rid="CR53">53</xref>,
  <xref ref-type="bibr" rid="CR54">54</xref>,
  <xref ref-type="bibr" rid="CR56">56</xref>,
  <xref ref-type="bibr" rid="CR60">60</xref>,
  <xref ref-type="bibr" rid="CR65">65</xref>,
  <xref ref-type="bibr" rid="CR67">67</xref>,
  <xref ref-type="bibr" rid="CR71">71</xref>,
  <xref ref-type="bibr" rid="CR76">76</xref>,
  <xref ref-type="bibr" rid="CR82">82</xref>,
  <xref ref-type="bibr" rid="CR88">88</xref>
 </sup>. Consistently, studies reported reductions in neurite length, branching, and network complexity
 <sup>
  <xref ref-type="bibr" rid="CR42">42</xref>,
  <xref ref-type="bibr" rid="CR45">45</xref>,
  <xref ref-type="bibr" rid="CR49">49</xref>,
  <xref ref-type="bibr" rid="CR51">51</xref>,
  <xref ref-type="bibr" rid="CR53">53</xref>,
  <xref ref-type="bibr" rid="CR54">54</xref>,
  <xref ref-type="bibr" rid="CR56">56</xref>,
  <xref ref-type="bibr" rid="CR60">60</xref>,
  <xref ref-type="bibr" rid="CR65">65</xref>,
  <xref ref-type="bibr" rid="CR67">67</xref>,
  <xref ref-type="bibr" rid="CR71">71</xref>,
  <xref ref-type="bibr" rid="CR76">76</xref>,
  <xref ref-type="bibr" rid="CR82">82</xref>,
  <xref ref-type="bibr" rid="CR88">88</xref>
 </sup>. However, incidences of hyperbranching
 <sup>
  <xref ref-type="bibr" rid="CR26">26</xref>
 </sup> and lack of neurite alterations have also been reported
 <sup>
  <xref ref-type="bibr" rid="CR37">37</xref>
 </sup>. In addition, irregular presynaptic membranous inclusions and dystrophic synaptic structures were reported in a neuronal model of synucleinopathy
 <sup>
  <xref ref-type="bibr" rid="CR73">73</xref>
 </sup>. The exact mechanism underlying neurite alterations in PD neurons remains unclear and can be attributed either to dysfunction in neurite morphogenesis or increased neurite deterioration
 <sup>
  <xref ref-type="bibr" rid="CR42">42</xref>
 </sup>. Elevation in autophagic flux, in response to Î±-synuclein and Tau accumulation, was associated with the reduction of neurite structure and outgrowth in patient lines
 <sup>
  <xref ref-type="bibr" rid="CR49">49</xref>,
  <xref ref-type="bibr" rid="CR53">53</xref>
 </sup>. Induction of the initiation of autophagy or inhibition of its completion also greatly exacerbated the neurite alterations in patient dopamine neurons
 <sup>
  <xref ref-type="bibr" rid="CR26">26</xref>,
  <xref ref-type="bibr" rid="CR56">56</xref>
 </sup>. Microtubule instability induced by the depolymerizing agent colchicine and loss of 
 <italic>PRKN</italic> function also resulted in neural aberrations, though not specifically in TH+ cells
 <sup>
  <xref ref-type="bibr" rid="CR54">54</xref>
 </sup>. Both autophagy and microtubule polymerization play key roles in neurite injury, growth and axonal formation, and impairments in either of these mechanisms can mediate the neurite alterations observed in PD neurons
 <sup>
  <xref ref-type="bibr" rid="CR217">217</xref>,
  <xref ref-type="bibr" rid="CR218">218</xref>
 </sup>.
</p>
